| CSF biomarker variability in the Alzheimer's Association quality control program N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ... Alzheimer's & Dementia 9 (3), 251-261, 2013 | 396 | 2013 |
| Soluble oligomers of amyloid-β peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway C Malaplate-Armand, S Florent-Béchard, I Youssef, V Koziel, I Sponne, ... Neurobiology of disease 23 (1), 178-189, 2006 | 257 | 2006 |
| Docosahexaenoic acid prevents neuronal apoptosis induced by soluble amyloid‐β oligomers S Florent, C Malaplate‐Armand, I Youssef, B Kriem, V Koziel, ... Journal of neurochemistry 96 (2), 385-395, 2006 | 224 | 2006 |
| Cytosolic phospholipase A2 mediates neuronal apoptosis induced by soluble oligomers of the amyloid‐β peptide B Kriem, I Sponne, A Fifre, C Malaplate‐Armand, K Lozac'h‐Pillot, ... The FASEB Journal 19 (1), 85-87, 2005 | 174 | 2005 |
| Alzheimer’s disease: treatment strategies and their limitations E Passeri, K Elkhoury, M Morsink, K Broersen, M Linder, A Tamayol, ... International journal of molecular sciences 23 (22), 13954, 2022 | 158 | 2022 |
| Ciliary neurotrophic factor cell-based delivery prevents synaptic impairment and improves memory in mouse models of Alzheimer's disease P Garcia, I Youssef, JK Utvik, S Florent-Béchard, V Barthélémy, ... Journal of Neuroscience 30 (22), 7516-7527, 2010 | 143 | 2010 |
| N-truncated amyloid-β oligomers induce learning impairment and neuronal apoptosis I Youssef, S Florent-Béchard, C Malaplate-Armand, V Koziel, B Bihain, ... Neurobiology of aging 29 (9), 1319-1333, 2008 | 119 | 2008 |
| The essential role of lipids in Alzheimer's disease S Florent-Bechard, C Desbene, P Garcia, A Allouche, I Youssef, ... Biochimie 91 (6), 804-809, 2009 | 85 | 2009 |
| Critical role of cPLA2 in Aβ oligomer-induced neurodegeneration and memory deficit C Desbène, C Malaplate-Armand, I Youssef, P Garcia, C Stenger, ... Neurobiology of aging 33 (6), 1123. e17-1123. e29, 2012 | 67 | 2012 |
| Long-term ACE inhibitor/ARB use is associated with severe renal dysfunction and acute kidney injury in patients with severe COVID-19: results from a referral center cohort in … A Oussalah, S Gleye, I Clerc Urmes, E Laugel, J Callet, F Barbé, ... Clinical Infectious Diseases 71 (9), 2447-2456, 2020 | 65 | 2020 |
| Additional use of Aβ 42/Aβ 40 ratio with cerebrospinal fluid biomarkers P-tau and Aβ 42 increases the level of evidence of Alzheimer's disease pathophysiological process in … M Sauvee, G DidierLaurent, C Latarche, MC Escanye, JL Olivier, ... Journal of Alzheimer's Disease 41 (2), 377-386, 2014 | 61 | 2014 |
| Membrane raft domains and remodeling in aging brain J Colin, L Gregory-Pauron, MC Lanhers, T Claudepierre, C Corbier, ... Biochimie 130, 178-187, 2016 | 54 | 2016 |
| Oxidative stress impairs glutamate uptake in fibroblasts from patients with Alzheimer's disease B Begni, L Brighina, E Sirtori, L Fumagalli, S Andreoni, S Beretta, T Oster, ... Free Radical Biology and Medicine 37 (6), 892-901, 2004 | 52 | 2004 |
| Towards a nutritional approach for prevention of Alzheimer's disease: biochemical and cellular aspects S Florent-Béchard, C Malaplate-Armand, V Koziel, B Kriem, JL Olivier, ... Journal of the neurological sciences 262 (1-2), 27-36, 2007 | 51 | 2007 |
| Use of dipeptidyl peptidase‐4 inhibitors and prognosis of COVID‐19 in hospitalized patients with type 2 diabetes: A propensity score analysis from the CORONADO study R Roussel, P Darmon, M Pichelin, T Goronflot, Y Abouleka, L Ait Bachir, ... Diabetes, Obesity and Metabolism 23 (5), 1162-1172, 2021 | 40 | 2021 |
| Up‐regulation of hepatic lipolysis stimulated lipoprotein receptor by leptin: a potential lever for controlling lipid clearance during the postprandial phase C Stenger, M Hanse, D Pratte, ML Mbala, S Akbar, V Koziel, MC Escanyé, ... The FASEB Journal 24 (11), 4218-4228, 2010 | 40 | 2010 |
| The spectrum of biochemical alterations associated with organ dysfunction and inflammatory status and their association with disease outcomes in severe COVID-19: A longitudinal … A Oussalah, S Gleye, IC Urmes, E Laugel, F Barbe, S Orlowski, ... EClinicalMedicine 27, 2020 | 37 | 2020 |
| Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview C Delaby, CE Teunissen, K Blennow, D Alcolea, I Arisi, EB Amar, ... Alzheimer's & Dementia 18 (10), 1868-1879, 2022 | 35 | 2022 |
| Cerebrospinal fluid Aβ 42/Aβ 40 as a means to limiting tube-and storage-dependent pre-analytical variability in clinical setting C Gervaise-Henry, G Watfa, E Albuisson, A Kolodziej, B Dousset, ... Journal of Alzheimer's Disease 57 (2), 437-445, 2017 | 35 | 2017 |
| Astroglial CYP1B1 up-regulation in inflammatory/oxidative toxic conditions: IL-1β effect and protection by N-acetylcysteine C Malaplate-Armand, L Ferrari, C Masson, G Siest, AM Batt Toxicology letters 138 (3), 243-251, 2003 | 35 | 2003 |
kriem badreddineMCU universite de Lorraine在 univ-lorraine.fr 的电子邮件经过验证
